Sanjay Warrier, MBBS, MS, FRACS
Breast Surgeon; Associate Professor; Medical Advisor, Learn Look Locate
Medical School
University of New South Wales
MBBS / BSc (Medicine)
Residency
Royal Prince Alfred Hospital, Sydney
General Surgery Training Program
Post-Graduate Degrees
Fellow of the Royal Australasian College of Surgeons (FRACS)
Breast & Oncology Fellowship – Prince of Wales Hospital
Clinical Breast & Research Fellowship – Royal Prince Alfred Hospital
Area of Expertise
Breast Cancer Surgery
Surgical Innovation & Technology Adoption
Quality & Outcome-Focused Breast Cancer Care
Breast Cancer Education, Research & Advocacy
Reducing Surgical and Reconstructive Complications
Years of Experience
Over 20 years
Certifications & Professional Standing
Fellow of the Royal Australasian College of Surgeons (FRACS)
Associate Professor of Breast Surgery, University of Sydney
Former President, BreastSurgANZ
Biography
Dr Sanjay Warrier is a highly respected breast surgeon, academic leader, and surgical innovator based in Sydney, Australia, whose work has had a significant impact on breast cancer care across Australia, New Zealand, and the global surgical community. With over two decades of experience, Dr Warrier has dedicated his career to advancing breast cancer surgery through evidence-based practice, innovation, and education—always with a focus on improving outcomes and quality of life for patients.
Dr Warrier is a Breast Surgeon at the Chris O’Brien Lifehouse Cancer Centre and a Visiting Medical Officer at Royal Prince Alfred Hospital, one of Australia’s leading tertiary referral centers. Alongside his clinical work, he serves as an Associate Professor of Breast Surgery at the University of Sydney, where he plays a pivotal role in training and mentoring future breast surgeons. He is also the Founder and Course Coordinator of the Masters of Breast Surgery program, reflecting his deep commitment to surgical education and academic excellence.
Internationally recognized for his leadership in surgical innovation, Dr. Warrier has been at the forefront of integrating advanced technologies into breast cancer surgery. His work includes fluorescence-guided surgery, radar localization, negative pressure wound therapy, pre-operative 3D surgical planning, and robot-assisted techniques—advances that have helped reduce surgical complications and improve reconstructive outcomes for patients. He has served as a key opinion leader in fluorescence imaging technology and has led numerous clinical trials and registries focused on surgical decision-making and patient-centred outcomes.
Dr Warrier’s influence extends beyond the operating room. He has held national leadership roles, including serving as President of BreastSurgANZ, the peak professional body for breast surgeons in Australia and New Zealand. Through these roles, he has helped shape surgical training standards, clinical guidelines, and quality frameworks that influence breast cancer care across the region.
A prolific researcher and international collaborator, Dr. Warrier has authored and co-authored an extensive body of peer-reviewed research published in leading surgical and oncology journals. He is a frequently invited speaker at international conferences and contributes to global conversations on the future of breast cancer surgery, innovation, and outcomes-based care.
Awards, Honors & Recognitions:
- India Australia Business & Community Alliance Science, Research & Development Award (2025)
- Certificate of Commendation, NSW Parliament Legislative Council (2025)
- Winner, Patron’s Prize for Scientific Research, Royal Prince Alfred Hospital (2013)
- Key Opinion Leader in SPY® Elite Fluorescence Imaging Technology in Australia
- Independent Expert Witness in breast surgery and oncology (2019–present)
National Leadership, Boards & Professional Recognition
- Former President, BreastSurgANZ (Australia & New Zealand)
- Executive Council Member, BreastSurgANZ
- Chairman of Post Fellowship Training, BreastSurgANZ (2014–2019)
- Site Director of Surgical Training, Royal Prince Alfred Hospital
- Principal Investigator and Coordinating Principal Investigator on multiple national and international breast cancer registries and trials
- Advisor to Cancer Australia on breast cancer screening strategy and implementation
- Reviewer for the British Journal of Surgery (BJS)
- Board Member, SBCF
- Member, Royal Australasian College of Surgeons (RACS)
- Member, Australian Society of Breast Disease
- Member, General Surgeons Australia
- Member, Oncoplastic Surgery Subcommittee
- Member, BreastScreen advisory and working groups
- Member, ANZ Breast Cancer Trials Group (ANZBCT)
- Contributor to national and international clinical guidelines, educational programs, and quality improvement initiatives in breast cancer care
Surgical Innovation & Technology-Focused Research
- Development of a plasma lipidomic signature for early detection of breast cancer. Breast Cancer Trials ASM.
- Developing an indocyanine green angiography protocol for predicting flap necrosis during breast reconstruction. Surgical Innovation. 2025.
- Indocyanine green angiographic predictors of reconstructive complications following nipple-sparing mastectomy. JPRAS Open. 2024.
- Mastectomy skin flap necrosis after implant-based reconstruction: intraoperative predictors using ICG angiography. Journal of Plastic, Reconstructive & Aesthetic Surgery.
- Evolution of indocyanine green fluorescence in breast and axilla surgery: an Australasian experience. Life. 2024.
- Indocyanine green compared with technetium-99m for sentinel lymph node biopsy. The Breast. 2024.
- Targeted axillary dissection: institutional experience at Chris O’Brien Lifehouse. The Breast. 2024.
- Utility of indocyanine green angiography in delaying breast reconstruction post-mastectomy. European Journal of Plastic Surgery.
- Patterns of ischaemia and reperfusion in nipple-sparing mastectomy reconstruction with ICG angiography. JPRAS.
- Cost-effectiveness of indocyanine green angiography in post-mastectomy breast reconstruction. Journal of Plastic, Reconstructive & Aesthetic Surgery.
- Trends in outcomes following adoption of ICG angiography in reconstruction. ANZ Journal of Surgery.
- Practice-changing cases using ICG technology in breast reconstruction. Biomedical Journal of Scientific & Technical Research.
- Value of indocyanine green angiography in robotic surgical procedures. Journal of Endourology Case Reports.
Foundational, Collaborative & Earlier Career Publications
- Stromal cell diversity associated with immune evasion in triple-negative breast cancer. The EMBO Journal.
- Single-Cell and Spatial Atlas of Human Breast Cancers. Nature Genetics.
- Cryopreservation of human cancers preserves tumour heterogeneity. Genome Medicine.
- Programmed death ligand-1 expression in triple-negative breast cancer. Histopathology.
- Window of opportunity treatment in breast cancer. ANZ Journal of Surgery.
- Immediate expander/implant reconstruction followed by radiotherapy. The Breast.
- Role of negative pressure wound therapy in implant salvage.
- Metaplastic carcinoma with mesenchymal differentiation.
- Phyllodes tumour case series and reviews.
- Breast cancer screening and management updates.
- Silicone injections and breast cancer systematic review.
- Lactational breast abscess outcomes.
- Anatomical variations of the intercostobrachial nerve.
- Core biopsy accuracy in retroperitoneal sarcoma.
- Claudin-1 as a transcriptional target predicting poor breast cancer outcome. ASCO.
Selected Recent & High-Impact Publications
Associate Professor Sanjay Warrier has authored and co-authored an extensive body of peer-reviewed research published in leading international surgical and oncology journals. His work spans surgical innovation, outcomes-based breast cancer care, translational research, and global collaboration.
To ensure clarity and ease of navigation, publications are organized below by focus area.
- Florid xanthogranulomatous reaction to breast implants: an unusual presentation of Erdheim-Chester disease. Pathology. 2025.
- Association of Axillary Lymph Node Dissection with Oncological Outcomes in Patients with Residual Micrometastases after Neoadjuvant Chemotherapy: OPBC-07/microNAC Study. 2025.
- Indocyanine green versus technetium-99m for sentinel lymph node biopsy in breast cancer: The FLUORO Trial. BJS Open. 2025.
- Indocyanine Green Fluorescence-Guided Axillary Reverse Mapping for Axillary Lymph Node Dissection: The FARM Trial. Annals of Surgical Oncology. 2025.
- Verification of the BREASTEST assay in an Australian population: A novel liquid biopsy for early-stage breast cancer screening. Journal of Clinical Oncology. 2025.
- How to do indocyanine green fluorescence-guided axillary sentinel lymph node biopsy in breast cancer: the sunrise effect. ANZ Journal of Surgery. 2025.
- Closed incision negative pressure wound therapy in oncoplastic breast surgery. The Surgeon. 2025.
- Detailed DNA methylation characterisation of phyllodes tumours identifying a malignancy signature. Journal of Pathology. 2024.
- Avoiding unnecessary sentinel lymph node biopsy using superparamagnetic iron oxide mapping agents (Magtrace®). ANZ Journal of Surgery. 2024.
Cost-effectiveness of radar localisation versus wire localisation for non-palpable breast cancer. Annals of Surgical Oncology. 2024.
Axillary Surgery, Neoadjuvant Therapy & Surgical Decision-Making
- Patient-reported impact of oncoplastic breast conservation vs mastectomy with reconstruction. Archives of Breast Cancer.
- Axillary dissection versus radiotherapy in sentinel node-positive breast cancer: meta-analysis. 2023.
- Neoadjuvant chemotherapy in non-metastatic breast cancer: the surgeon’s perspective. The Surgeon. 2023.
- Nomogram predicting nodal positivity in older breast cancer patients. The Surgeon. 2023.
- Dual tracer indocyanine green and radioisotope sentinel node biopsy: GREENORBLUE Trial. Annals of Surgical Oncology.
- Trends in post-mastectomy breast reconstruction rates in Australia. ANZ Journal of Surgery.
- Positive anterior margins in breast-conserving surgery: systematic review. The Breast.
- Preservation versus division of the intercostobrachial nerve in axillary dissection: meta-analysis. Cancer Research.
- Management of micrometastatic axillary disease.
- Factors predictive for malignancy in atypical ductal hyperplasia.
- Predicting non-sentinel lymph node metastasis in Australian breast cancer patients.
Complete Publication Record
Associate Professor Warrier’s complete publication record includes extensive work across:
- Fluorescence-guided and indocyanine green (ICG) angiography–assisted surgery
- Surgical innovation and technology adoption
- Axillary surgery and sentinel lymph node management
- Neoadjuvant therapy and surgical decision-making
- Breast reconstruction outcomes and complication reduction
- Translational and molecular breast cancer research
- Multinational collaborative trials and registries
His publications appear in leading journals, including Nature Genetics, Journal of Clinical Oncology, Annals of Surgical Oncology, The Breast, ANZ Journal of Surgery, Journal of Plastic, Reconstructive & Aesthetic Surgery, The EMBO Journal, and BJS, among others.
A full academic curriculum vitae is available upon request.
featured Articles
FDA Updates Mammography Regulations to Require Reports
The FDA updates mammography regulations to require facilities to notify patients about breast density to improve mammogram assessments.
The Future in 3D: Revolutionizing Breast Cancer Screening
Despite overall advances in cancer treatment, Black women face higher mortality rates and more aggressive forms of the disease.
The Emergence of AI in Mammography
Discover how AI is transforming breast cancer screening, increasing detection rates by 20%. Explore the future of mammography with AI.
Featured Interview
The Secret in Monthly Breast Exams. What You Need to Know
Testimonial
MEET OUR EXPERT MEDICAL TEAM
Explore the expertise of our medical advisors, who are dedicated to advancing breast cancer awareness, treatment, and support. Connect with our team and discover how their guidance contributes to the resources and insights available within our breast cancer support groups.

























